Active surveillance (AS) for prostate cancer includes follow‐up with serial prostate biopsies. The optimal biopsy frequency during follow‐up has not been determined. The goal of this investigation was to use… Click to show full abstract
Active surveillance (AS) for prostate cancer includes follow‐up with serial prostate biopsies. The optimal biopsy frequency during follow‐up has not been determined. The goal of this investigation was to use longitudinal AS biopsy data to assess whether the frequency of biopsy could be reduced without substantially prolonging the time to the detection of disease with a Gleason score ≥ 7.
               
Click one of the above tabs to view related content.